Progenics Pharmaceuticals (PGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 44,377 | 7,862 | 14,048 | 84,796 | 7,952 |
| Gross Profit | 44,377 | 7,862 | 14,048 | 84,796 | 7,952 |
| Operating Expenses | 41,007 | 50,842 | 49,539 | 74,480 | 77,836 |
| Operating Income | 3,370 | -42,980 | -35,491 | 10,316 | -69,884 |
| Interest Expense | -51 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 46 | 60 | 65 | 64 |
| Pre-tax Income | 3,421 | -42,934 | -35,431 | 10,381 | -69,820 |
| Income Tax | -989 | -362 | 0 | 0 | -95 |
| Net Income Continuous | 4,410 | -42,572 | -35,431 | 10,381 | -69,725 |
| Net Income | $4,410 | $-42,572 | $-35,431 | $10,381 | $-69,725 |
| EPS Basic Total Ops | 0.06 | -0.76 | -1.02 | 0.31 | -2.14 |
| EPS Basic Continuous Ops | 0.06 | -0.76 | -1.02 | 0.31 | -2.14 |
| EPS Diluted Total Ops | 0.06 | -0.76 | -1.02 | 0.31 | -2.14 |
| EPS Diluted Continuous Ops | 0.06 | -0.76 | -1.02 | 0.31 | -2.14 |
| EPS Diluted Before Non-Recurring Items | 0.06 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $6,591 | $-41,122 | $-34,167 | $12,382 | $-67,031 |